Publications by authors named "Fouad Attieh"

Claim this Profile
T
Turning the Tables: How Encorafenib and Binimetinib are Reshaping NSCLC Treatment.
John-Victor El Khoury, Marc Boutros, Fouad Attieh, Hampig Raphaël Kourie

Cancer Invest· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is escalated BEACOPP dead? Rethinking standards in hodgkin lymphoma treatment.
Colette Hanna, Fouad Attieh, Hampig Raphaël Kourie, Fadi G Haddad

Med Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing enfortumab vedotin plus pembrolizumab therapy.
Elias Antoine Karam, Yaghi César Céline, Gilles Prince, Fouad Attieh, Hampig Raphael Kourie

Oncotarget· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enter sandman: how to tackle dormant breast cancer cells.
Fouad Attieh, Reina Al Khatib, Marc Boutros, Antoine Mouawad, Hampig Raphaël Kourie

Med Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden: why is it still a controversial agnostic immunotherapy biomarker?
Antoine Mouawad, Marc Boutros, Antoine Chartouni, Fouad Attieh, Hampig Raphaël Kourie

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer.
Antoine Mouawad, Sofia Habib, Marc Boutros, Fouad Attieh, Hampig Raphaël Kourie

Future Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advancements at ASCO 2024 in PD-L1 and PD-1 bispecific antibodies.
Shaza Hammad, Marc Boutros, Fouad Attieh, Hampig Raphaël Kourie

Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical review of RAF inhibitors in BRAF-mutated glioma treatment.
John-Victor El Khoury, Sophie Wehbe, Fouad Attieh, Marc Boutros, Carole Kesrouani

Pharmacogenomics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turning the tide: pembrolizumab's triumph in adjuvant RCC therapy.
Fouad Attieh, Marc Boutros, Hampig Raphaël Kourie, Mervat Mahrous

Med Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking barriers: the latest insights into KRAS G12C inhibitors.
Fouad Attieh, Hampig Raphaël Kourie

Future Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tackling the immunotherapy conundrum: advances and challenges for operable non-small-cell lung cancer treatment.
Fouad Attieh, Antoine Chartouni, Marc Boutros, Antoine Mouawad, Hampig Raphaël Kourie

Immunotherapy· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the Horizon: A Cutting-Edge Review of the Latest Checkpoint Inhibitors in Cancer Treatment.
Marc Boutros, Fouad Attieh, Antoine Chartouni, Johnny Jalbout, Hampig Raphaël Kourie

Cancer Invest· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cells: a trojan horse to treat glioblastoma.
Antoine Chartouni, Antoine Mouawad, Marc Boutros, Fouad Attieh, Nicolas Medawar

Invest New Drugs· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis